Small extracellular vesicles as biomarkers of response in recurrent/metastatic HNSCC patients treated with immunotherapy
Abstract Background Biomarkers that effectively predict response to anti-PD-1 mAb therapy in cancer patients are an unmet need. We evaluated the utility of small extracellular vesicles (sEV) as biomarkers of response to immunotherapy in recurrent/metastatic (R/M) head and neck squamous cell carcinom...
| Published in: | BJC Reports |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2024-09-01
|
| Online Access: | https://doi.org/10.1038/s44276-024-00096-0 |
